Anorexiants Market
Market Insights on Anorexiants covering sales outlook, demand forecast & up-to-date key trends
Anorexiants Market By Drug Class, Route of Administration, End User & Region - Forecast 2022 – 2032
Anorexiants Market Outlook (2022-2032)
[250 Pages Report] The global anorexiant market is expected to reach a valuation of approximately US$ 1 Bn in 2022. Sales in the anorexiants market are likely to increase at a CAGR of 5.3% over the forecast period. Growth can be attributed to the rising prevalence of obesity. As per a May 2022 report published by the CDC, the U.S. recorded an increase from 35% to 41.9%; from the year 1990-2000 through 2017-2020.
In 2021, WHO reported that 39 million children under the age of 5 and over 600 million adults are obese. This factor is fueling expenditure in the healthcare sector, which is expected to underpin demand for anorexiants in the forthcoming years.
|
Report Attribute |
Details |
|
Anorexiants Market Estimated Size (2022) |
US$ 1 Bn |
|
Anorexiants Market Projected Growth Rate (2022-2032) |
5.3% CAGR |
Let us know your requirement to get
100% FREE customization
How High Prevalence of Obesity is Fueling Sales of Anorexiants?
Anorexiants are therapeutics used in the management of obesity. These drugs work by repressing appetite; inducing satiety, and thereby decreasing the food intake. As the rate of obesity, which is identified as the root cause of most preventable diseases, increases across the globe; sales in the anorexiant market will increase.
Upsurge in geriatric population, rising government initiatives to spread awareness, along with increasing disposable income are some factors contributing to the growth in the market.
Another factor that is central to rising demand for anorexiants is the increase in investments in the healthcare sector. Private and government agencies are investing in the expansion of the healthcare sector in various countries. These investments, along rising research & developmental activities, emergence of new players, and advancing technology create a conducive environment for the expansion of the anorexiants market.
Which Regions are Leading the Anorexiant Market?
The anorexiants market, internationally, is split into seven key regions: North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding Japan, and Middle East & Africa. North America is estimated to be the largest market for anorexiants because of high rates of obesity and its approach towards the adoption of new drugs.
The rise in the development of new drugs, easy sanctions of drugs, and advancement in healthcare facilities and technologies have contributed to the growth of the anorexiants market in Europe.
Asia Pacific is expected to emerge as a lucrative pocket in the global anorexiants market owing to rising demand for new and improved treatment options. Further, growing cases of weight gain and consequent obesity act as a stimulant for demand in the anorexiants market.
Compared to the scope of growth in regions such as North America, Europe, Asia Pacific, the Middle East, and Africa are less contributing areas. Poor healthcare facilities, fewer instances of new drug adoption, and a lack of awareness among the population are some factors that hinder the growth in the anorexiant market in these regions.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Factors are Obstructing the Growth in the Anorexiants Market?
Certain challenges that the anorexiants market faces is high cost of development and distribution of drugs. Poor healthcare facilities, lack of skilled professionals as well as low awareness among people might limit sales of anorexiants. Further, resultant side-effects from the consumption of the drug also impede the growth in the market.
What are the Key Trends Influencing Sales of Anorexiants?
Demand for oral anorexiants is estimated to remain high over the forecast period due to patients’ preference for non-invasive treatments, and the ease of administration of oral anorexiants. Additionally, the easy availability of the product in the form of tablets and capsules, as well as well-informed key players are also expected to boost sales in the forthcoming years.
Another notable trend is the continued dominance of North America in the market due to rising prevalence of obesity and related diseases, easy adoption of new drugs, the presence of key players, and high awareness among consumers. These factors will place North America as the leading anorexiants market over the assessment period.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Market Competition
Leading players operating in the global anorexiants market are investing in research and development to improve their product portfolios. They are also aiming at production facility expansions through mergers, acquisitions and collaborations.
For instance, in 2019, Currax Pharmaceuticals LLC, gained the global rights to Contrave, the leading prescription for weight loss in the United States and Europe after acquiring Nalpropion Pharmaceuticals, a biopharmaceutical company focused on weight loss treatment.
Some of the key players operating in the market include Akrimax Pharmaceuticals, LLC, Teva Pharmaceuticals, Janssen Ortho, LLC, Roche Pharmaceuticals, Arena Pharmaceuticals GmbH, Novo Nordisk A/S, Abbott Pharmaceuticals PR Ltd, Epic Pharma, LLC., Patheon Pharmaceuticals Inc., Catalent Pharma Solutions, LLC, Recordati Rare Diseases Inc., and MOVA Pharmaceuticals.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 5.3% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2015-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million, Volume in Kilotons and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Countries Covered |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Anorexiants Market Survey
By Drug Class:
- Catecholamines Anorexiants
- Serotonin Anorexiants
By Route of Administration:
- Oral
- Subcutaneous
By End User:
- Institutional sales
- Hospitals
- Clinics
- Retail sales
- Online pharmacies
- Mail Order Pharmacies
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Frequently Asked Questions
The global anorexiants market is projected to expand at a 5.3% CAGR over the assessment period.
High incidence of obesity, along with increasing investments in the healthcare sector by private and government agencies across emerging economies will augment sales of anorexiants in the forthcoming years.
Akrimax Pharmaceuticals, LLC, Teva Pharmaceuticals, Janssen Ortho, LLC, Roche Pharmaceuticals, and Arena Pharmaceuticals GmbH are some of the key manufacturers of anorexiants.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Anorexiants Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Class
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Drug Class, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Drug Class, 2022-2032
5.3.1. Catecholamines Anorexiants
5.3.2. Serotonin Anorexiants
5.4. Y-o-Y Growth Trend Analysis By Drug Class, 2017-2021
5.5. Absolute $ Opportunity Analysis By Drug Class, 2022-2032
6. Global Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Route of Administration, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Route of Administration, 2022-2032
6.3.1. Oral
6.3.2. Subcutaneous
6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017-2021
6.5. Absolute $ Opportunity Analysis By Route of Administration, 2022-2032
7. Global Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By End User, 2022-2032
7.3.1. Institutional Sales
7.3.2. Hospitals
7.3.3. Clinics
7.3.4. Retail Sales
7.3.5. Online Pharmacies
7.3.6. Mail Order Pharmacies
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
8. Global Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Drug Class
9.2.3. By Route of Administration
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Drug Class
9.3.3. By Route of Administration
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Mexico
10.2.1.2. Brazil
10.2.1.3. Rest of Latin America
10.2.2. By Drug Class
10.2.3. By Route of Administration
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Drug Class
10.3.3. By Route of Administration
10.3.4. By End User
10.4. Key Takeaways
11. Europe Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Rest of Europe
11.2.2. By Drug Class
11.2.3. By Route of Administration
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Drug Class
11.3.3. By Route of Administration
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Drug Class
12.2.3. By Route of Administration
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Drug Class
12.3.3. By Route of Administration
12.3.4. By End User
12.4. Key Takeaways
13. South Asia & Pacific Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. ASEAN
13.2.1.3. Australia and New Zealand
13.2.1.4. Rest of South Asia & Pacific
13.2.2. By Drug Class
13.2.3. By Route of Administration
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Drug Class
13.3.3. By Route of Administration
13.3.4. By End User
13.4. Key Takeaways
14. MEA Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Turkey
14.2.1.3. South Africa
14.2.1.4. Rest of MEA
14.2.2. By Drug Class
14.2.3. By Route of Administration
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Drug Class
14.3.3. By Route of Administration
14.3.4. By End User
14.4. Key Takeaways
15. Key Countries Anorexiants Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Drug Class
15.1.2.2. By Route of Administration
15.1.2.3. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Drug Class
15.2.2.2. By Route of Administration
15.2.2.3. By End User
15.3. Mexico
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Drug Class
15.3.2.2. By Route of Administration
15.3.2.3. By End User
15.4. Brazil
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Drug Class
15.4.2.2. By Route of Administration
15.4.2.3. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Drug Class
15.5.2.2. By Route of Administration
15.5.2.3. By End User
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Drug Class
15.6.2.2. By Route of Administration
15.6.2.3. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Drug Class
15.7.2.2. By Route of Administration
15.7.2.3. By End User
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Drug Class
15.8.2.2. By Route of Administration
15.8.2.3. By End User
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Drug Class
15.9.2.2. By Route of Administration
15.9.2.3. By End User
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Drug Class
15.10.2.2. By Route of Administration
15.10.2.3. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Drug Class
15.11.2.2. By Route of Administration
15.11.2.3. By End User
15.12. China
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Drug Class
15.12.2.2. By Route of Administration
15.12.2.3. By End User
15.13. Japan
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Drug Class
15.13.2.2. By Route of Administration
15.13.2.3. By End User
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Drug Class
15.14.2.2. By Route of Administration
15.14.2.3. By End User
15.15. India
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Drug Class
15.15.2.2. By Route of Administration
15.15.2.3. By End User
15.16. ASEAN
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Drug Class
15.16.2.2. By Route of Administration
15.16.2.3. By End User
15.17. Australia and New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Drug Class
15.17.2.2. By Route of Administration
15.17.2.3. By End User
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Drug Class
15.18.2.2. By Route of Administration
15.18.2.3. By End User
15.19. Turkey
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Drug Class
15.19.2.2. By Route of Administration
15.19.2.3. By End User
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Drug Class
15.20.2.2. By Route of Administration
15.20.2.3. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Drug Class
16.3.3. By Route of Administration
16.3.4. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Teva Pharmaceuticals
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Janssen Ortho, LLC
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Roche Pharmaceuticals
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Pfizer
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Novo Nordisk A/S
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Abbott Pharmaceuticals PR Ltd.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Epic Pharma, LLC.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Patheon Pharmaceuticals Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Catalent Pharma Solutions, LLC
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Recordati Rare Diseases Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. MOVA Pharmaceuticals
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 1: Global Anorexiants Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Anorexiants Market Volume (Tons) Forecast by Region, 2017-2032
Table 3: Global Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032
Table 4: Global Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032
Table 5: Global Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032
Table 6: Global Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032
Table 7: Global Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 8: Global Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032
Table 9: North America Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: North America Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032
Table 11: North America Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032
Table 12: North America Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032
Table 13: North America Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032
Table 14: North America Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032
Table 15: North America Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 16: North America Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032
Table 17: Latin America Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: Latin America Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032
Table 19: Latin America Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032
Table 20: Latin America Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032
Table 21: Latin America Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032
Table 22: Latin America Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032
Table 23: Latin America Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 24: Latin America Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032
Table 25: Europe Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: Europe Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032
Table 27: Europe Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032
Table 28: Europe Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032
Table 29: Europe Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032
Table 30: Europe Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032
Table 31: Europe Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 32: Europe Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032
Table 33: East Asia Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 34: East Asia Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032
Table 35: East Asia Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032
Table 36: East Asia Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032
Table 37: East Asia Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032
Table 38: East Asia Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032
Table 39: East Asia Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 40: East Asia Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032
Table 41: South Asia & Pacific Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 42: South Asia & Pacific Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032
Table 43: South Asia & Pacific Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032
Table 44: South Asia & Pacific Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032
Table 45: South Asia & Pacific Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032
Table 46: South Asia & Pacific Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032
Table 47: South Asia & Pacific Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 48: South Asia & Pacific Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032
Table 49: MEA Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 50: MEA Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032
Table 51: MEA Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032
Table 52: MEA Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032
Table 53: MEA Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032
Table 54: MEA Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032
Table 55: MEA Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 56: MEA Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Global Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032
Figure 2: Global Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 3: Global Anorexiants Market Value (US$ Mn) by End User, 2022-2032
Figure 4: Global Anorexiants Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global Anorexiants Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 6: Global Anorexiants Market Volume (Tons) Analysis by Region, 2017-2032
Figure 7: Global Anorexiants Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 8: Global Anorexiants Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 9: Global Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032
Figure 10: Global Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032
Figure 11: Global Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032
Figure 12: Global Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032
Figure 13: Global Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032
Figure 14: Global Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032
Figure 15: Global Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 16: Global Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 17: Global Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 18: Global Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032
Figure 19: Global Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 20: Global Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 21: Global Anorexiants Market Attractiveness by Drug Class, 2022-2032
Figure 22: Global Anorexiants Market Attractiveness by Route of Administration, 2022-2032
Figure 23: Global Anorexiants Market Attractiveness by End User, 2022-2032
Figure 24: Global Anorexiants Market Attractiveness by Region, 2022-2032
Figure 25: North America Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032
Figure 26: North America Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 27: North America Anorexiants Market Value (US$ Mn) by End User, 2022-2032
Figure 28: North America Anorexiants Market Value (US$ Mn) by Country, 2022-2032
Figure 29: North America Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 30: North America Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032
Figure 31: North America Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 32: North America Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 33: North America Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032
Figure 34: North America Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032
Figure 35: North America Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032
Figure 36: North America Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032
Figure 37: North America Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032
Figure 38: North America Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032
Figure 39: North America Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 40: North America Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 41: North America Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 42: North America Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032
Figure 43: North America Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 44: North America Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 45: North America Anorexiants Market Attractiveness by Drug Class, 2022-2032
Figure 46: North America Anorexiants Market Attractiveness by Route of Administration, 2022-2032
Figure 47: North America Anorexiants Market Attractiveness by End User, 2022-2032
Figure 48: North America Anorexiants Market Attractiveness by Country, 2022-2032
Figure 49: Latin America Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032
Figure 50: Latin America Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 51: Latin America Anorexiants Market Value (US$ Mn) by End User, 2022-2032
Figure 52: Latin America Anorexiants Market Value (US$ Mn) by Country, 2022-2032
Figure 53: Latin America Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 54: Latin America Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032
Figure 55: Latin America Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 56: Latin America Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 57: Latin America Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032
Figure 58: Latin America Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032
Figure 59: Latin America Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032
Figure 60: Latin America Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032
Figure 61: Latin America Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032
Figure 62: Latin America Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032
Figure 63: Latin America Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 64: Latin America Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 65: Latin America Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 66: Latin America Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032
Figure 67: Latin America Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 68: Latin America Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 69: Latin America Anorexiants Market Attractiveness by Drug Class, 2022-2032
Figure 70: Latin America Anorexiants Market Attractiveness by Route of Administration, 2022-2032
Figure 71: Latin America Anorexiants Market Attractiveness by End User, 2022-2032
Figure 72: Latin America Anorexiants Market Attractiveness by Country, 2022-2032
Figure 73: Europe Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032
Figure 74: Europe Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 75: Europe Anorexiants Market Value (US$ Mn) by End User, 2022-2032
Figure 76: Europe Anorexiants Market Value (US$ Mn) by Country, 2022-2032
Figure 77: Europe Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 78: Europe Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032
Figure 79: Europe Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 80: Europe Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 81: Europe Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032
Figure 82: Europe Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032
Figure 83: Europe Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032
Figure 84: Europe Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032
Figure 85: Europe Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032
Figure 86: Europe Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032
Figure 87: Europe Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 88: Europe Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 89: Europe Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 90: Europe Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032
Figure 91: Europe Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 92: Europe Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 93: Europe Anorexiants Market Attractiveness by Drug Class, 2022-2032
Figure 94: Europe Anorexiants Market Attractiveness by Route of Administration, 2022-2032
Figure 95: Europe Anorexiants Market Attractiveness by End User, 2022-2032
Figure 96: Europe Anorexiants Market Attractiveness by Country, 2022-2032
Figure 97: East Asia Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032
Figure 98: East Asia Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 99: East Asia Anorexiants Market Value (US$ Mn) by End User, 2022-2032
Figure 100: East Asia Anorexiants Market Value (US$ Mn) by Country, 2022-2032
Figure 101: East Asia Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 102: East Asia Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032
Figure 103: East Asia Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 104: East Asia Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 105: East Asia Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032
Figure 106: East Asia Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032
Figure 107: East Asia Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032
Figure 108: East Asia Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032
Figure 109: East Asia Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032
Figure 110: East Asia Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032
Figure 111: East Asia Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 112: East Asia Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 113: East Asia Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 114: East Asia Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032
Figure 115: East Asia Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 116: East Asia Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 117: East Asia Anorexiants Market Attractiveness by Drug Class, 2022-2032
Figure 118: East Asia Anorexiants Market Attractiveness by Route of Administration, 2022-2032
Figure 119: East Asia Anorexiants Market Attractiveness by End User, 2022-2032
Figure 120: East Asia Anorexiants Market Attractiveness by Country, 2022-2032
Figure 121: South Asia & Pacific Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032
Figure 122: South Asia & Pacific Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 123: South Asia & Pacific Anorexiants Market Value (US$ Mn) by End User, 2022-2032
Figure 124: South Asia & Pacific Anorexiants Market Value (US$ Mn) by Country, 2022-2032
Figure 125: South Asia & Pacific Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 126: South Asia & Pacific Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032
Figure 127: South Asia & Pacific Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 128: South Asia & Pacific Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 129: South Asia & Pacific Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032
Figure 130: South Asia & Pacific Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032
Figure 131: South Asia & Pacific Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032
Figure 132: South Asia & Pacific Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032
Figure 133: South Asia & Pacific Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032
Figure 134: South Asia & Pacific Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032
Figure 135: South Asia & Pacific Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 136: South Asia & Pacific Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 137: South Asia & Pacific Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 138: South Asia & Pacific Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032
Figure 139: South Asia & Pacific Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 140: South Asia & Pacific Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 141: South Asia & Pacific Anorexiants Market Attractiveness by Drug Class, 2022-2032
Figure 142: South Asia & Pacific Anorexiants Market Attractiveness by Route of Administration, 2022-2032
Figure 143: South Asia & Pacific Anorexiants Market Attractiveness by End User, 2022-2032
Figure 144: South Asia & Pacific Anorexiants Market Attractiveness by Country, 2022-2032
Figure 145: MEA Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032
Figure 146: MEA Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 147: MEA Anorexiants Market Value (US$ Mn) by End User, 2022-2032
Figure 148: MEA Anorexiants Market Value (US$ Mn) by Country, 2022-2032
Figure 149: MEA Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 150: MEA Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032
Figure 151: MEA Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 152: MEA Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 153: MEA Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032
Figure 154: MEA Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032
Figure 155: MEA Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032
Figure 156: MEA Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032
Figure 157: MEA Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032
Figure 158: MEA Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032
Figure 159: MEA Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 160: MEA Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 161: MEA Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 162: MEA Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032
Figure 163: MEA Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 164: MEA Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 165: MEA Anorexiants Market Attractiveness by Drug Class, 2022-2032
Figure 166: MEA Anorexiants Market Attractiveness by Route of Administration, 2022-2032
Figure 167: MEA Anorexiants Market Attractiveness by End User, 2022-2032
Figure 168: MEA Anorexiants Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
